Xeris Biopharma Holdings, Inc. (XERS) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | $554.0K | +101.0% |
| 2024 | -$54.84M | +11.9% |
| 2023 | -$62.26M | +34.2% |
| 2022 | -$94.66M | +22.9% |
| 2021 | -$122.72M | -34.7% |
| 2020 | -$91.14M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | $554.0K | +101.0% |
| 2024 | -$54.84M | +11.9% |
| 2023 | -$62.26M | +34.2% |
| 2022 | -$94.66M | +22.9% |
| 2021 | -$122.72M | -34.7% |
| 2020 | -$91.14M | — |